Jeffrey J. Peters

Cardialen, Inc. develops medical devices. It offers pain-free cardio version therapy for atrial fibrillation (AF) using low-energy implantable atrial cardioverters. The firm develops and commercializes these as an independent specialist, to address major needs in atrial fibrillation management, achieve improved outcomes and reduce the risk of stroke, heart failure and high healthcare costs associated with atrial fibrillation. The company's products comprise implantable low-energy pain-free atrial cardioverters and cardiac leads and defibrillator equipment. Its products are used for the treatment of atrial and ventricular arrhythmias. Cardialen was founded in 2008 by D. Graeme Thomas, Randy H. Weiss and Igor R. Efimov and is headquartered in St. Louis, MO.

OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London.

NeuroVasc Technologies, Inc. provides heath care services. The firm engages in the research and development of medical devices. The company was founded on January 19, 2016 and is headquartered in Laguna Hills, CA.

Anulex Technologies, Inc. develops medical technologies. It focuses on the research and development of medical technologies to preserve and repair soft tissue of the spine for patients undergoing a surgical procedure to remove a herniated disc. The company was founded in 2001 by Matthew M. Burns and is headquartered in Minneapolis, MN.

Founded in 2001, Foundation Medical Partners is a venture capital firm located in Rowayton, Connecticut. The firm is affiliated with the Cleveland Clinic

A division of Cargill Financial Services, Black River Asset Management LLC is an independently run global hedge fund manager located in Hopkins, Minnesota. The firm is wholly-owned by Cargill, Inc. and was founded in 2003.

ev3, Inc. is a provider for specialists treating a range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a portfolio of treatment options, including interventional technologies used such as plaque excision systems, PTA balloons, stents, embolic protection, thrombectomy, embolization coils, liquid embolics, occlusion balloons and procedural support.

Children's Health Care engages in the operation of a children's hospital. It offers emergency and trauma care, primary care, surgery, walk-in ready care, specialty care and departments, family services, and education materials. The company was founded in 1924 and is headquartered in Minneapolis, MN.